- Home
- TOI vs OSUR Comparison
TOI vs OSUR Comparison
Compare TOI & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOI
- OSUR
- Stock Information
- Founded
- TOI 2007
- OSUR 2000
- Country
- TOI United States
- OSUR United States
- Employees
- TOI N/A
- OSUR N/A
- Industry
- TOI Medical/Nursing Services
- OSUR Medical/Dental Instruments
- Sector
- TOI Health Care
- OSUR Health Care
- Exchange
- TOI Nasdaq
- OSUR Nasdaq
- Market Cap
- TOI 266.8M
- OSUR 228.1M
- IPO Year
- TOI N/A
- OSUR 1986
- Fundamental
- Price
- TOI $3.68
- OSUR $3.36
- Analyst Decision
- TOI Strong Buy
- OSUR Hold
- Analyst Count
- TOI 1
- OSUR 1
- Target Price
- TOI $6.00
- OSUR $3.00
- AVG Volume (30 Days)
- TOI 2.5M
- OSUR 738.5K
- Earning Date
- TOI 08-12-2025
- OSUR 08-05-2025
- Dividend Yield
- TOI N/A
- OSUR N/A
- EPS Growth
- TOI N/A
- OSUR N/A
- EPS
- TOI N/A
- OSUR N/A
- Revenue
- TOI $403,152,000.00
- OSUR $161,626,000.00
- Revenue This Year
- TOI $23.95
- OSUR N/A
- Revenue Next Year
- TOI N/A
- OSUR $6.80
- P/E Ratio
- TOI N/A
- OSUR N/A
- Revenue Growth
- TOI 17.64
- OSUR N/A
- 52 Week Low
- TOI $0.13
- OSUR $2.36
- 52 Week High
- TOI $3.88
- OSUR $4.92
- Technical
- Relative Strength Index (RSI)
- TOI 66.52
- OSUR 63.50
- Support Level
- TOI $3.26
- OSUR $3.25
- Resistance Level
- TOI $3.88
- OSUR $3.51
- Average True Range (ATR)
- TOI 0.31
- OSUR 0.18
- MACD
- TOI 0.08
- OSUR 0.02
- Stochastic Oscillator
- TOI 86.93
- OSUR 43.90
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.